Literature DB >> 1696807

Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen.

D Crevat1, J M Crance, A M Chevrinais, J Passagot, E Biziagos, G Somme, R Deloince.   

Abstract

Two monoclonal antibodies (813 and 10.09) were raised against hepatitis A virus (HAV). They recognize an immunodominant epitope and a neutralizing site on HAV.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1696807     DOI： 10.1007/bf01318357

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  13 in total

1.  Propagation of human hepatitis A virus in cell culture in vitro.

Authors:  P J Provost; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-02

2.  Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology.

Authors:  J M Crance; J Passagot; E Biziagos; R Deloince
Journal:  J Virol Methods       Date:  1987-11       Impact factor: 2.014

3.  Monoclonal antibodies against hepatitis A virus.

Authors:  A MacGregor; M Kornitschuk; J G Hurrell; N I Lehmann; A G Coulepis; S A Locarnini; I D Gust
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

Review 4.  Taxonomic classification of hepatitis A virus.

Authors:  I D Gust; A G Coulepis; S M Feinstone; S A Locarnini; Y Moritsugu; R Najera; G Siegl
Journal:  Intervirology       Date:  1983       Impact factor: 1.763

5.  A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody.

Authors:  R H Purcell; D C Wong; Y Moritsugu; J L Dienstag; J A Routenberg; J D Boggs
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

6.  Effect of glutaraldehyde on the antigenicity and infectivity of hepatitis A virus.

Authors:  J Passagot; J M Crance; E Biziagos; H Laveran; F Agbalika; R Deloince
Journal:  J Virol Methods       Date:  1987-05       Impact factor: 2.014

7.  Effect of antiviral substances on hepatitis A virus replication in vitro.

Authors:  E Biziagos; J M Crance; J Passagot; R Deloince
Journal:  J Med Virol       Date:  1987-05       Impact factor: 2.327

8.  Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV.

Authors:  E A Brown; R W Jansen; S M Lemon
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Monoclonal antibodies to hepatitis A virus.

Authors:  G J Dawson; R H Decker; D K Norton; W H Bryce; R O Whittington; I I Tribby; I K Mushahwar
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

10.  [Release of hepatitis A virus into the culture medium, during its replication in PLC/PRF/5 cells].

Authors:  J M Crance; R Deloince; C Lechevallier; D Crevat; H Laveran; R Fontanges
Journal:  C R Seances Acad Sci III       Date:  1983
View more
  3 in total

1.  Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1.

Authors:  E Silberstein; G Dveksler; G G Kaplan
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus.

Authors:  G Kaplan; A Totsuka; P Thompson; T Akatsuka; Y Moritsugu; S M Feinstone
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

3.  Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies.

Authors:  L H Ping; S M Lemon
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.